Literature DB >> 16137572

Alterations in the phenotype of neocortical pyramidal cells in the Dyrk1A+/- mouse.

R Benavides-Piccione1, M Dierssen, I Ballesteros-Yáñez, M Martínez de Lagrán, M L Arbonés, V Fotaki, J DeFelipe, G N Elston.   

Abstract

The gene encoding the dual-specificity tyrosine-regulated kinase DYRK1A maps to the chromosomal segment HSA21q22.2, which lies within the Down syndrome critical region. The reduction in brain size and behavioral defects observed in mice lacking one copy of the murine homologue Dyrk1A (Dyrk1A+/-) support the idea that this kinase may be involved in monosomy 21 associated mental retardation. However, the structural basis of these behavioral defects remains unclear. In the present work, we have analyzed the microstructure of cortical circuitry in the Dyrk1A+/- mouse and control littermates by intracellular injection of Lucifer Yellow in fixed cortical tissue. We found that labeled pyramidal cells were considerably smaller, less branched and less spinous in the cortex of Dyrk1A+/- mice than in control littermates. These results suggest that Dyrk1A influences the size and complexity of pyramidal cells, and thus their capability to integrate information.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16137572     DOI: 10.1016/j.nbd.2005.02.004

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  35 in total

1.  Alterations of cortical pyramidal neurons in mice lacking high-affinity nicotinic receptors.

Authors:  Inmaculada Ballesteros-Yáñez; Ruth Benavides-Piccione; Jean-Pierre Bourgeois; Jean-Pierre Changeux; Javier DeFelipe
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

2.  Prefrontal deficits in a murine model overexpressing the down syndrome candidate gene dyrk1a.

Authors:  Aurore Thomazeau; Olivier Lassalle; Jillian Iafrati; Benoit Souchet; Fayçal Guedj; Nathalie Janel; Pascale Chavis; Jean Delabar; Olivier J Manzoni
Journal:  J Neurosci       Date:  2014-01-22       Impact factor: 6.167

3.  Gene dosage-dependent association of DYRK1A with the cytoskeleton in the brain and lymphocytes of down syndrome patients.

Authors:  Karol Dowjat; Tatyana Adayev; Wojciech Kaczmarski; Jerzy Wegiel; Yu-Wen Hwang
Journal:  J Neuropathol Exp Neurol       Date:  2012-12       Impact factor: 3.685

4.  Ten new cases further delineate the syndromic intellectual disability phenotype caused by mutations in DYRK1A.

Authors:  Lucas M Bronicki; Claire Redin; Severine Drunat; Amélie Piton; Michael Lyons; Sandrine Passemard; Clarisse Baumann; Laurence Faivre; Julien Thevenon; Jean-Baptiste Rivière; Bertrand Isidor; Grace Gan; Christine Francannet; Marjolaine Willems; Murat Gunel; Julie R Jones; Joseph G Gleeson; Jean-Louis Mandel; Roger E Stevenson; Michael J Friez; Arthur S Aylsworth
Journal:  Eur J Hum Genet       Date:  2015-04-29       Impact factor: 4.246

5.  DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies.

Authors:  Jianling Ji; Hane Lee; Bob Argiropoulos; Naghmeh Dorrani; John Mann; Julian A Martinez-Agosto; Natalia Gomez-Ospina; Natalie Gallant; Jonathan A Bernstein; Louanne Hudgins; Leah Slattery; Bertrand Isidor; Cédric Le Caignec; Albert David; Ewa Obersztyn; Barbara Wiśniowiecka-Kowalnik; Michelle Fox; Joshua L Deignan; Eric Vilain; Emily Hendricks; Margaret Horton Harr; Sarah E Noon; Jessi R Jackson; Alisha Wilkens; Ghayda Mirzaa; Noriko Salamon; Jeff Abramson; Elaine H Zackai; Ian Krantz; A Micheil Innes; Stanley F Nelson; Wayne W Grody; Fabiola Quintero-Rivera
Journal:  Eur J Hum Genet       Date:  2015-05-06       Impact factor: 4.246

6.  Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A.

Authors:  Yasushi Ogawa; Yosuke Nonaka; Toshiyasu Goto; Eriko Ohnishi; Toshiyuki Hiramatsu; Isao Kii; Miyo Yoshida; Teikichi Ikura; Hiroshi Onogi; Hiroshi Shibuya; Takamitsu Hosoya; Nobutoshi Ito; Masatoshi Hagiwara
Journal:  Nat Commun       Date:  2010-10-05       Impact factor: 14.919

7.  Sprouty2-mediated inhibition of fibroblast growth factor signaling is modulated by the protein kinase DYRK1A.

Authors:  Sergi Aranda; Mónica Alvarez; Silvia Turró; Ariadna Laguna; Susana de la Luna
Journal:  Mol Cell Biol       Date:  2008-08-04       Impact factor: 4.272

8.  Impaired development of neocortical circuits contributes to the neurological alterations in DYRK1A haploinsufficiency syndrome.

Authors:  Juan Arranz; Elisa Balducci; Krisztina Arató; Gentzane Sánchez-Elexpuru; Sònia Najas; Alberto Parras; Elena Rebollo; Isabel Pijuan; Ionas Erb; Gaetano Verde; Ignasi Sahun; Maria J Barallobre; José J Lucas; Marina P Sánchez; Susana de la Luna; Maria L Arbonés
Journal:  Neurobiol Dis       Date:  2019-03-01       Impact factor: 5.996

9.  DYRK3 dual-specificity kinase attenuates erythropoiesis during anemia.

Authors:  Olga Bogacheva; Oleg Bogachev; Madhu Menon; Arvind Dev; Estelle Houde; Elizabeth I Valoret; Haydn M Prosser; Caretha L Creasy; Susan J Pickering; Evelyn Grau; Kim Rance; George P Livi; Vinit Karur; Connie L Erickson-Miller; Don M Wojchowski
Journal:  J Biol Chem       Date:  2008-10-14       Impact factor: 5.157

10.  Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly.

Authors:  Rikke S Møller; Sabine Kübart; Maria Hoeltzenbein; Babett Heye; Ida Vogel; Christian P Hansen; Corinna Menzel; Reinhard Ullmann; Niels Tommerup; Hans-Hilger Ropers; Zeynep Tümer; Vera M Kalscheuer
Journal:  Am J Hum Genet       Date:  2008-04-10       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.